We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+23.43%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$16.4B
AUM Growth
-$5.58B
(-25%)
Cap. Flow
-$3.87B
Cap. Flow
% of AUM
-23.65%
Top 10 Holdings %
Top 10 Hldgs %
18.07%
Holding
3,458
New
283
Increased
974
Reduced
1,077
Closed
907
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$97.1M |
| 2 |
iShares Core S&P Small-Cap ETF
IJR
|
+$76.6M |
| 3 |
Lowe's Companies
LOW
|
+$75.4M |
| 4 |
Monster Beverage
MNST
|
+$64.6M |
| 5 |
FISV
Fiserv Inc
FISV
|
+$63.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Accenture
ACN
|
+$114M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$109M |
| 3 |
Trane Technologies
TT
|
+$106M |
| 4 |
Microsoft
MSFT
|
+$104M |
| 5 |
Mastercard
MA
|
+$104M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.03% |
| 2 | Healthcare | 13.89% |
| 3 | Financials | 11.27% |
| 4 | Consumer Discretionary | 8.92% |
| 5 | Industrials | 8.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Eli Lilly
LLY
$1.07T
| $82.4M | 0.5% |
501,905
-17,168
| -3% | -$2.64M |
|
52
ExxonMobil
XOM
$651B
| $80.7M | 0.49% |
1,805,345
-107,853
| -6% | -$4.84M |
|
53
Paychex
PAYX
$40.4B
| $80.4M | 0.49% |
1,061,686
-13,912
| -1% | -$964K |
|
54
3M
MMM
$89B
| $78.7M | 0.48% |
603,286
+162,915
| +37% | +$20.5M |
|
55
Cencora
COR
$60.3B
| $75.7M | 0.46% |
751,616
-5,201
| -0.7% | -$479K |
|
56
Dollar Tree
DLTR
$23.1B
| $74.8M | 0.46% |
807,043
+295,934
| +58% | +$24.7M |
|
57
Vanguard FTSE Developed Markets ETF
VEA
$226B
| $74.2M | 0.45% |
1,912,641
-930,201
| -33% | -$34M |
|
58
Lennar Class A
LEN
$20.4B
| $73.7M | 0.45% |
1,235,160
+1,233,972
| +103,870% | +$63M |
|
59
Lockheed Martin
LMT
$134B
| $72.7M | 0.44% |
199,350
+154,923
| +349% | +$58.5M |
|
|
60
Monster Beverage
MNST
$91.4B
| $72.2M | 0.44% |
2,082,428
+1,977,064
| +1,876% | +$64.6M |
|
61
Chubb
CB
$140B
| $71.3M | 0.44% |
563,081
+34,250
| +6% | +$3.97M |
|
62
iShares Russell 2000 ETF
IWM
$80.9B
| $71.2M | 0.43% |
496,969
+106,935
| +27% | +$14M |
|
63
Costco
COST
$415B
| $71.1M | 0.43% |
234,622
+101,513
| +76% | +$30.9M |
|
64
Regeneron Pharmaceuticals
REGN
$68.8B
| $70.8M | 0.43% |
113,494
+3,557
| +3% | +$2.02M |
|
65
McDonald's
MCD
$188B
| $68.3M | 0.42% |
370,015
-35,633
| -9% | -$6.53M |
|
66
SS&C Technologies
SSNC
$17.8B
| $67.3M | 0.41% |
1,190,852
+811,686
| +214% | +$44.2M |
|
67
Gilead Sciences
GILD
$161B
| $64.6M | 0.4% |
840,178
+83,410
| +11% | +$6.39M |
|
68
Vanguard Dividend Appreciation ETF
VIG
$111B
| $64.6M | 0.39% |
551,220
+21,108
| +4% | +$2.4M |
|
|
FISV
69
Fiserv Inc
FISV
$27.2B
| $63.4M | 0.39% |
649,930
+631,814
| +3,488% | +$63.6M |
|
70
PNC Financial Services
PNC
$100B
| $63.4M | 0.39% |
602,771
-39,968
| -6% | -$4.21M |
|
71
US Bancorp
USB
$99.6B
| $63.4M | 0.39% |
1,722,209
+333,525
| +24% | +$11.9M |
|
72
UnitedHealth
UNH
$382B
| $63.3M | 0.39% |
214,486
-276,668
| -56% | -$79.3M |
|
73
NextEra Energy
NEE
$187B
| $63M | 0.38% |
1,048,512
-48,620
| -4% | -$2.91M |
|
74
Ameriprise Financial
AMP
$46.8B
| $62.8M | 0.38% |
418,697
-29,891
| -7% | -$3.83M |
|
75
Target
TGT
$62.1B
| $61.6M | 0.38% |
513,878
-101,511
| -16% | -$11.6M |
|
Similar funds
SLAM
EWA
MIC
P
OSAM
CB
EIM
Glenmede Trust's Q2 2020 Portfolio in Review
As of Q2 2020, Glenmede Trust held 3,458 positions worth $16.4B, down 25% from $21.9B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Glenmede Trust withdrew a net $3.87B in Q2 2020, closing 907 positions and reducing 1,077 holdings. Its most notable exit was Raytheon Company, an estimated $66.5M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Glenmede Trust opened a new position in Carrier Global worth $21.3M.
- Glenmede Trust's largest Q2 2020 buy was Carrier Global: 960,042 shares worth $21.3M.
- Glenmede Trust added most to State Street SPDR S&P 500 ETF Trust in Q2 2020, an estimated $97.1M increase.
- Glenmede Trust's biggest Q2 2020 reduction was Accenture, cutting an estimated $114M.
- Glenmede Trust fully exited Raytheon Company in Q2 2020, selling an estimated $66.5M.
- Glenmede Trust's ten largest holdings make up 18% of its $16.4B portfolio in Q2 2020.
- Glenmede Trust opened 283 new positions and closed 907 in Q2 2020.
- Glenmede Trust's portfolio value fell 25% quarter-over-quarter to $16.4B.
Based on Glenmede Trust's 13F filing for Q2 2020, filed 14 Aug 2020.